These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8456211)

  • 1. Using autoregressive and random walk models to detect trends and shifts in unequally spaced tumour biomarker data.
    Schlain BR; Lavin PT; Hayden CL
    Stat Med; 1993 Feb; 12(3-4):265-79. PubMed ID: 8456211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using an autoregressive model to detect departures from steady states in unequally spaced tumour biomarker data.
    Schlain BR; Lavin PT; Hayden CL
    Stat Med; 1992 Feb; 11(4):515-32. PubMed ID: 1609182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic use of tumor markers in the follow-up of patients operated for primary breast cancer.
    Gion M; Fila G; Biasioli R; Vignati G; Mione R; Saracchini S; Rinaldi E; Testa E; Bruscagnin G
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):1-7. PubMed ID: 2092100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is follow-up of breast cancer with CEA and CA 15-3 justified?].
    Fritsche E; Benz J
    Helv Chir Acta; 1992 May; 59(1):225-9. PubMed ID: 1526832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery.
    Nakamura T; Kimura T; Umehara Y; Suzuki K; Okamoto K; Okumura T; Morizumi S; Kawabata T
    Surg Today; 2005; 35(1):19-21. PubMed ID: 15622458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements.
    Jäger W
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():133-9. PubMed ID: 8298443
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.
    Safi F; Kohler I; Röttinger E; Beger H
    Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in the diagnosis and prognosis of breast cancer].
    Seliuzhitskiĭ IV; Skvortsov SV; Lytsar BN; Khomenko LP
    Klin Med (Mosk); 1993; 71(2):25-7. PubMed ID: 8046917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the estrogen and progesterone receptor content of primary breast cancers without skeletal or visceral metastasis with tumor marker MCA, CEA and CA 15-3 serum concentration at the time of surgery].
    Seifert M; Wierrani F; Kubista E; Spona J
    Gynakol Rundsch; 1991; 31 Suppl 2():397-8. PubMed ID: 1790992
    [No Abstract]   [Full Text] [Related]  

  • 10. CEA and CA 15-3 in primary and recurrent breast cancer.
    O'Dwyer PJ; Duffy MJ; O'Sullivan F; McDermott E; Losty P; O'Higgins NJ
    World J Surg; 1990; 14(5):562-5; discussion 565-6. PubMed ID: 2238654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unequally spaced longitudinal data with AR(1) serial correlation.
    Jones RH; Boadi-Boateng F
    Biometrics; 1991 Mar; 47(1):161-75. PubMed ID: 2049497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers in metastatic breast carcinoma: correlations with clinical response].
    Winer Y; Martini MC; Pastorino G; Moraglio L; Vallauri M; Brondi P; Brema F
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):127-30. PubMed ID: 2092107
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers].
    Stapel A; Franke U; Putzki H
    Zentralbl Chir; 1992; 117(2):77-80. PubMed ID: 1315472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and immunohistochemical studies of NCC-ST-439 in breast cancer.
    Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
    J Surg Oncol; 1993 Sep; 54(1):5-8. PubMed ID: 8377506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor marker combination versus second-look operation in ovarian cancer].
    Lahousen M; Stettner H; Pürstner P; Pickel H
    Zentralbl Gynakol; 1990; 112(9):561-6. PubMed ID: 2378187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperatory kinetic evaluation of tumor markers in breast and colorectal carcinoma.
    Gion M; Ruggeri G; Marconato R; Casella C; Nosadini A; Laffranchini G; Mione R; Belloli S; Bruscagnin G
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):9-12. PubMed ID: 2092156
    [No Abstract]   [Full Text] [Related]  

  • 18. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling of serial carcinoembryonic antigen changes in colorectal cancer.
    Carl J; Bentzen SM; Nørgaard-Pedersen B; Kronborg O
    Scand J Clin Lab Invest; 1993 Nov; 53(7):751-5. PubMed ID: 8272763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual cutoff levels of carcinoembryonic antigen and CA 242 indicate recurrence of colorectal cancer with high sensitivity.
    Engarås B
    Dis Colon Rectum; 2003 Mar; 46(3):313-21. PubMed ID: 12626905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.